Login to Your Account

Washington Roundup

More Transparency Hasn't Translated into Import Safety

By Mari Serebrov
Washington Editor

Wednesday, May 22, 2013
Despite an increase in transparency and collaboration in China, the safety of drugs and other products imported from the country remains a concern in the U.S. Currently, the FDA has 74 active import alerts, many of which involve Chinese companies, and nine countrywide alerts pertaining to China.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription